FUROSCIX DIRECT Trademark

Trademark Overview


On Thursday, November 17, 2022, a trademark application was filed for FUROSCIX DIRECT with the United States Patent and Trademark Office. The USPTO has given the FUROSCIX DIRECT trademark a serial number of 97681853. The federal status of this trademark filing is REGISTERED as of Tuesday, January 23, 2024. This trademark is owned by scPharmaceuticals Inc.. The FUROSCIX DIRECT trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, and Transportation & Storage Services categories with the following description:

Financial administration of medication reimbursement programs and services; Financial administration of pharmacy reimbursement programs and services

home delivery of medical products

Business administration of medication reimbursement programs and services; Business administration of pharmacy reimbursement programs and services
furoscix direct

General Information


Serial Number97681853
Word MarkFUROSCIX DIRECT
Filing DateThursday, November 17, 2022
Status700 - REGISTERED
Status DateTuesday, January 23, 2024
Registration Number7289009
Registration DateTuesday, January 23, 2024
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 11, 2023

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Goods and ServicesFinancial administration of medication reimbursement programs and services; Financial administration of pharmacy reimbursement programs and services
Certificate of Correction for RegistrationIn the statement, line 1, "scPharmaceuticals, Inc." and "Massachusetts " should be deleted, and "scPharmaceuticals Inc." and "Delaware" should be inserted.
Description of MarkThe mark consists of the word "FUROSCIX" in larger font above the word "DIRECT" in smaller font together with a triangular shaped design.
Goods and Serviceshome delivery of medical products
Goods and ServicesBusiness administration of medication reimbursement programs and services; Business administration of pharmacy reimbursement programs and services
NOT AVAILABLE"DIRECT"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2023
Primary Code035
First Use Anywhere DateMonday, February 27, 2023
First Use In Commerce DateMonday, February 27, 2023

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateThursday, December 8, 2022
Primary Code036
First Use Anywhere DateMonday, February 27, 2023
First Use In Commerce DateMonday, February 27, 2023

International Class039 - Transport; packaging and storage of goods; travel arrangement.
US Class Codes100, 105
Class Status Code6 - Active
Class Status DateTuesday, January 24, 2023
Primary Code039
First Use Anywhere DateMonday, February 27, 2023
First Use In Commerce DateMonday, February 27, 2023

Trademark Owner History


Party NamescPharmaceuticals Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Party NamescPharmaceuticals Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Party NamescPharmaceuticals Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events


Event DateEvent Description
Monday, November 21, 2022NEW APPLICATION ENTERED
Thursday, December 8, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, December 9, 2022NOTICE OF DESIGN SEARCH CODE E-MAILED
Friday, January 13, 2023ASSIGNED TO EXAMINER
Monday, January 23, 2023EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
Monday, January 23, 2023EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Monday, January 23, 2023NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
Tuesday, January 24, 2023ASSIGNED TO LIE
Tuesday, January 24, 2023COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED
Wednesday, February 22, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 22, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 11, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 11, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 5, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 5, 2023SOU EXTENSION 1 FILED
Tuesday, December 5, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 5, 2023TEAS STATEMENT OF USE RECEIVED
Thursday, December 7, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 5, 2023USE AMENDMENT FILED
Friday, December 15, 2023STATEMENT OF USE PROCESSING COMPLETE
Friday, December 15, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, December 16, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 23, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, January 23, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Monday, December 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, October 22, 2025TEAS SECTION 7 REQUEST RECEIVED
Saturday, November 22, 2025CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, November 24, 2025CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, December 16, 2025NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED